Literature DB >> 30074147

Involvement of X-chromosome Reactivation in Augmenting Cancer Testis Antigens Expression: A Hypothesis.

Chang Liu1, Bin Luo2,3, Xiao-Xun Xie2,3, Xing-Sheng Liao1, Jun Fu2, Ying-Ying Ge2,3, Xi-Sheng Li1, Gao-Shui Guo1, Ning Shen4, Shao-Wen Xiao5, Qing-Mei Zhang6,7.   

Abstract

Cancer testis antigens (CTAs) are attractive targets for tumor immunotherapy because of their tumor-specific expression. Since more than half of confirmed CTAs are located on the X-chromosome, we asked whether there is a link between CTA expression and X-chromosomes. Recent reports have shown that reactivation of the inactive X-chromosome, known as X-chromosome reactivation (XCR), a unique phenomenon that exists in many high-risk tumors in women, can transform the expression of many X-linked genes from monoallelic to biallelic. In this review, we discuss the link between CTA and XCR with the hopes of providing some novel insights into tumor biology.

Entities:  

Keywords:  X-chromosome reactivation; cancer testis antigen; tumor immunotherapy

Mesh:

Substances:

Year:  2018        PMID: 30074147     DOI: 10.1007/s11596-018-1842-0

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  39 in total

1.  Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2.

Authors:  M D'Esposito; N A Quaderi; A Ciccodicola; P Bruni; T Esposito; M D'Urso; S D Brown
Journal:  Mamm Genome       Date:  1996-07       Impact factor: 2.957

2.  A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping.

Authors:  Suhas S P Rao; Miriam H Huntley; Neva C Durand; Elena K Stamenova; Ivan D Bochkov; James T Robinson; Adrian L Sanborn; Ido Machol; Arina D Omer; Eric S Lander; Erez Lieberman Aiden
Journal:  Cell       Date:  2014-12-11       Impact factor: 41.582

3.  Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.

Authors:  Bin Luo; Xiang Yun; Rong Fan; Yong-Da Lin; Shu-Jia He; Qing-Mei Zhang; Fa-Rong Mo; Fang Chen; Shao-Wen Xiao; Xiao-Xun Xie
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

4.  Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.

Authors:  Yunzhao Xu; Chenyi Wang; Yuquan Zhang; Lizhou Jia; Jianfei Huang
Journal:  Sci Rep       Date:  2015-07-15       Impact factor: 4.379

5.  A rapid passage through a two-active-X-chromosome state accompanies the switch of imprinted X-inactivation patterns in mouse trophoblast stem cells.

Authors:  Julie Prudhomme; Agnès Dubois; Pablo Navarro; Danielle Arnaud; Philip Avner; Céline Morey
Journal:  Epigenetics Chromatin       Date:  2015-12-01       Impact factor: 4.954

6.  Rapid evolution of cancer/testis genes on the X chromosome.

Authors:  Brian J Stevenson; Christian Iseli; Sumir Panji; Monique Zahn-Zabal; Winston Hide; Lloyd J Old; Andrew J Simpson; C Victor Jongeneel
Journal:  BMC Genomics       Date:  2007-05-23       Impact factor: 3.969

7.  Treatment with 5-Aza-2'-Deoxycytidine Induces Expression of NY-ESO-1 and Facilitates Cytotoxic T Lymphocyte-Mediated Tumor Cell Killing.

Authors:  Agnes S Klar; Jakka Gopinadh; Sascha Kleber; Andreas Wadle; Christoph Renner
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

8.  Bipartite structure of the inactive mouse X chromosome.

Authors:  Xinxian Deng; Wenxiu Ma; Vijay Ramani; Andrew Hill; Fan Yang; Ferhat Ay; Joel B Berletch; Carl Anthony Blau; Jay Shendure; Zhijun Duan; William S Noble; Christine M Disteche
Journal:  Genome Biol       Date:  2015-08-07       Impact factor: 13.583

9.  Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes.

Authors:  Anne-Valerie Gendrel; Y Amy Tang; Masako Suzuki; Jonathan Godwin; Tatyana B Nesterova; John M Greally; Edith Heard; Neil Brockdorff
Journal:  Mol Cell Biol       Date:  2013-06-10       Impact factor: 4.272

10.  Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy.

Authors:  Pragya Srivastava; Benjamin E Paluch; Junko Matsuzaki; Smitha R James; Golda Collamat-Lai; Nadja Blagitko-Dorfs; Laurie Ann Ford; Rafeh Naqash; Michael Lübbert; Adam R Karpf; Michael J Nemeth; Elizabeth A Griffiths
Journal:  Oncotarget       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.